Biotech Booms: Tome’s $213M Tops Week’s 10 Massive Fundings
Tome Biosciences emerged from stealth with a $213 million combination series A and B funding from investors such as Andreessen Horowitz Bio + Health and Arch Venture Partners. Bicara Therapeutics raised a